Connection

TETSUO ASHIZAWA to Adolescent

This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Adolescent.
Connection Strength

0.227
  1. Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families. Cerebellum. 2019 Oct; 18(5):849-854.
    View in: PubMed
    Score: 0.046
  2. ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy. Cerebellum. 2025 Jan 16; 24(2):33.
    View in: PubMed
    Score: 0.017
  3. Delayed diagnosis of Friedreich's ataxia due to coexisting recessive deaf/blind syndrome. Neurology. 1998 Jun; 50(6):1924-5.
    View in: PubMed
    Score: 0.011
  4. Instability of the (CTG)n repeat in congenital myotonic dystrophy. Am J Hum Genet. 1997 Dec; 61(6):1445-8.
    View in: PubMed
    Score: 0.010
  5. Emerging therapies in Friedreich's ataxia. Neurodegener Dis Manag. 2016; 6(1):49-65.
    View in: PubMed
    Score: 0.009
  6. Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients. PLoS One. 2015; 10(2):e0117488.
    View in: PubMed
    Score: 0.008
  7. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014 Sep; 137(Pt 9):2444-55.
    View in: PubMed
    Score: 0.008
  8. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet. 1994 Mar; 54(3):414-23.
    View in: PubMed
    Score: 0.008
  9. Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms. PLoS One. 2013; 8(10):e76749.
    View in: PubMed
    Score: 0.008
  10. Diagnostic odyssey of patients with myotonic dystrophy. J Neurol. 2013 Oct; 260(10):2497-504.
    View in: PubMed
    Score: 0.008
  11. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013 Sep; 260(9):2362-9.
    View in: PubMed
    Score: 0.007
  12. Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
    View in: PubMed
    Score: 0.007
  13. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochem Biophys Res Commun. 2012 Aug 03; 424(3):404-8.
    View in: PubMed
    Score: 0.007
  14. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet. 1992 Jan 01; 42(1):55-60.
    View in: PubMed
    Score: 0.007
  15. Clinical and molecular diagnosis of a Costa Rican family with autosomal recessive myotonia congenita (Becker disease) carrying a new mutation in the CLCN1 gene. Rev Biol Trop. 2008 Mar; 56(1):1-11.
    View in: PubMed
    Score: 0.005
  16. Antioxidant use in Friedreich ataxia. J Neurol Sci. 2008 Apr 15; 267(1-2):174-6.
    View in: PubMed
    Score: 0.005
  17. Anticipation and intergenerational repeat instability in spinocerebellar ataxia type 17. Ann Neurol. 2007 Jun; 61(6):607-10.
    View in: PubMed
    Score: 0.005
  18. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet. 2006 Aug 17; 7:71.
    View in: PubMed
    Score: 0.005
  19. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology. 2006 Jun 13; 66(11):1711-6.
    View in: PubMed
    Score: 0.005
  20. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology. 2005 Apr 12; 64(7):1261-2.
    View in: PubMed
    Score: 0.004
  21. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004 Dec 28; 63(12):2280-7.
    View in: PubMed
    Score: 0.004
  22. Germline mutational dynamics in myotonic dystrophy type 1 males: allele length and age effects. Neurology. 2004 Jan 27; 62(2):269-74.
    View in: PubMed
    Score: 0.004
  23. [Significance of time-lapse changes in gallium-67 citrate accumulation in the diagnosis of hepatoma]. Kaku Igaku. 1983 Dec; 20(10):1449-58.
    View in: PubMed
    Score: 0.004
  24. Huntington's disease--like 2 can present as chorea-acanthocytosis. Neurology. 2003 Oct 14; 61(7):1002-4.
    View in: PubMed
    Score: 0.004
  25. [CT images of diffuse hepatic disease]. Rinsho Hoshasen. 1982 Dec; 27(13):1411-6.
    View in: PubMed
    Score: 0.004
  26. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol. 2001 Aug; 50(2):234-9.
    View in: PubMed
    Score: 0.003
  27. Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology. 2000 Jul 25; 55(2):224-30.
    View in: PubMed
    Score: 0.003
  28. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology. 1998 Oct; 51(4):1081-6.
    View in: PubMed
    Score: 0.003
  29. Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)? J Neurol. 1996 Oct; 243(10):715-21.
    View in: PubMed
    Score: 0.002
  30. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA. 1995 Sep 13; 274(10):813-9.
    View in: PubMed
    Score: 0.002
  31. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics. 1995 Jul 01; 28(1):1-14.
    View in: PubMed
    Score: 0.002
  32. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet. 1995 Jan; 56(1):114-22.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.